Trial Profile
A phase IIb study of CBM-CD20.1 in patients with advanced Non-Hodgkin Lymphoma
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 08 Mar 2024
Price :
$35
*
At a glance
- Drugs JNJ 90009530 (Primary)
- Indications Non-Hodgkin's lymphoma
- Focus Adverse reactions; Therapeutic Use
- 05 Nov 2015 New trial record